UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 29, 2003
King Pharmaceuticals,Inc.
(Exact name of registrant as specified in its charter)
| Tennessee (State or other jurisdiction of incorporation) |
0—24425 (Commission File Number) |
54-1684963 (IRS Employer Identification Number) |
| 501 Fifth Street, Bristol, Tennessee (Address of principal executive offices) |
37620 (Zip Code) |
Registrant’s telephone number, including area code: 423-989-8000
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events
King Pharmaceuticals, Inc., a Tennessee corporation, announced on July 29, 2003 the completion of the previously announced internal review conducted by the Audit Committee of King’s Board of Directors. Also, King filed with the Securities and Exchange Commission its Form 10-K containing the audited consolidated financial statements for the year ended December 31, 2002, and its Form 10-Q containing the unaudited consolidated financial statements for the first quarter ended March 31, 2003. On July 29, 2003, King issued a press release regarding the announcement.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
| The following exhibits are filed pursuant to Item 601 of Regulation S-K: |
Exhibits:
| Exhibit | ||||||||
| Number | Description of Exhibit | |||||||
99.1 |
Press Release of King Pharmaceuticals, Inc. dated July 29, 2003. | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 29, 2003
| KING PHARMACEUTICALS, INC. |
| By: /s/ James R. Lattanzi |
|
| James R. Lattanzi Chief Financial Officer |
Exhibit Index
| Exhibit | ||||||||
| Number | Description of Exhibit | |||||||
99.1 |
Press Release of King Pharmaceuticals, Inc. dated July 29, 2003. | |||||||